» Articles » PMID: 20838829

Characterization of the Osteoblast-specific Transmembrane Protein IFITM5 and Analysis of IFITM5-deficient Mice

Overview
Specialty Endocrinology
Date 2010 Sep 15
PMID 20838829
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Interferon-inducible transmembrane protein 5 (IFITM5) is an osteoblast-specific membrane protein whose expression peaks around the early mineralization stage during the osteoblast maturation process. To investigate IFITM5 function, we first sought to identify which proteins interact with IFITM5. Liquid chromatography mass spectrometry revealed that FK506-binding protein 11 (FKBP11) co-immunoprecipitated with IFITM5. FKBP11 is the only protein it was found to interact with in osteoblasts, while IFITM5 interacts with several proteins in fibroblasts. FKBPs are involved in protein folding and immunosuppressant binding, but we could not be sure that IFITM5 participated in these activities when bound to FKBP11. Thus, we generated Ifitm5-deficient mice and analyzed their skeletal phenotypes. The skeletons, especially the long bones, of homozygous mutants (Ifitm5(-/-)) were smaller than those of heterozygous mutants (Ifitm5(+/-)), although we did not observe any significant differences in bone morphometric parameters. The effect of Ifitm5 deficiency on bone formation was more significant in newborns than in young and adult mice, suggesting that Ifitm5 deficiency might have a greater effect on prenatal bone development. Overall, the effect of Ifitm5 deficiency on bone formation was less than we expected. We hypothesize that this may have resulted from a compensatory mechanism in Ifitm5-deficient mice.

Citing Articles

Identification of human cranio-maxillofacial skeletal stem cells for mandibular development.

Wang Z, Wang K, Yu Y, Fu J, Zhang S, Li M Sci Adv. 2025; 11(1):eado7852.

PMID: 39742474 PMC: 11691644. DOI: 10.1126/sciadv.ado7852.


Update on the Genetics of Osteogenesis Imperfecta.

Jovanovic M, Marini J Calcif Tissue Int. 2024; 115(6):891-914.

PMID: 39127989 PMC: 11607015. DOI: 10.1007/s00223-024-01266-5.


Evolution of primate interferon-induced transmembrane proteins (IFITMs): a story of gain and loss with a differentiation into a canonical cluster and IFITM retrogenes.

Schelle L, Abrantes J, Baldauf H, Esteves P Front Microbiol. 2023; 14:1213685.

PMID: 37577422 PMC: 10415907. DOI: 10.3389/fmicb.2023.1213685.


Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes.

Dicks A, Maksaev G, Harissa Z, Savadipour A, Tang R, Steward N Elife. 2023; 12.

PMID: 36810131 PMC: 9949800. DOI: 10.7554/eLife.71154.


Abnormal signal pathways and tumor heterogeneity in osteosarcoma.

Sun Y, Zhang C, Fang Q, Zhang W, Liu W J Transl Med. 2023; 21(1):99.

PMID: 36759884 PMC: 9912612. DOI: 10.1186/s12967-023-03961-7.


References
1.
Kelly J, GILBERT C, Stark G, Kerr I . Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons. Eur J Biochem. 1985; 153(2):367-71. DOI: 10.1111/j.1432-1033.1985.tb09312.x. View

2.
Rulten S, Kinloch R, Tateossian H, Robinson C, Gettins L, Kay J . The human FK506-binding proteins: characterization of human FKBP19. Mamm Genome. 2006; 17(4):322-31. DOI: 10.1007/s00335-005-0127-7. View

3.
Kay J . Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Biochem J. 1996; 314 ( Pt 2):361-85. PMC: 1217058. View

4.
Midura R, Wang A, Lovitch D, Law D, Powell K, Gorski J . Bone acidic glycoprotein-75 delineates the extracellular sites of future bone sialoprotein accumulation and apatite nucleation in osteoblastic cultures. J Biol Chem. 2004; 279(24):25464-73. DOI: 10.1074/jbc.M312409200. View

5.
Zucchi I, Bini L, Valaperta R, Ginestra A, Albani D, Susani L . Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin. Proc Natl Acad Sci U S A. 2001; 98(10):5608-13. PMC: 33260. DOI: 10.1073/pnas.091101898. View